An improved and efficient synthesis of Irbesartan, an antihypertensive drug
نویسندگان
چکیده
Development of a new improved and efficient process suitable for the large-scale production of Irbesartan has been described. The key steps are tetrazole formation from secondary amide for the preparation of the key intermediate 1-Benzyl-5-(4'-bromomethyl-biphenyl-2-yl)-1H-tetrazole (9), N-alkylation and debenzylation.
منابع مشابه
Clinical overview of irbesartan: a new angiotensin II receptor antagonist.
Irbesartan is an angiotensin II receptor (AT1 subtype) antagonist that has been extensively studied in the Bristol-Myers Squibb/Sanofi clinical development program. As shown in seven placebo controlled clinical trials, irbesartan provides clinically significant dose related reductions in blood pressure in patients with mild-to-moderate hypertension. Once daily dosing provides full 24 h blood pr...
متن کاملLong-term use and tolerability of irbesartan for control of hypertension
In this review, we discuss the pharmacological and clinical properties of irbesartan, a noncompetitive angiotensin II receptor type 1 antagonist, successfully used for more than a decade in the treatment of essential hypertension. Irbesartan exerts its antihypertensive effect through an inhibitory effect on the pressure response to angiotensin II. Irbesartan 150-300 mg once daily confers a last...
متن کاملZnO nanoparticles as an Efficient and Reusable Catalyst for Synthesis of Quinoxaline under Solvent Free Condition
1,2-Diketones have been reacted in one-pot method with 1,2-diamines at room temperature with ZnO nanoparticles as a catalyst. ZnO nanoparticles as an available and reusable catalyst is used for the synthesis of Quinoxalinein improved yields.
متن کاملIrbesartan improves arterial compliance more than lisinopril
BACKGROUND Antihypertensive agents can reduce arterial stiffness. We hypothesized that an angiotensin receptor blocker (ARB) irbesartan and an angiotensin converting enzyme inhibitor (ACEI) lisinopril improved arterial compliance. METHODS A randomized, double-blind, double-dummy, controlled crossover trial. Fifteen hypertensive patients, mean age 65.5 +/- 8.9 years (mean +/- SD) were given ir...
متن کاملZnO nanoparticles as an Efficient and Reusable Catalyst for Synthesis of Quinoxaline under Solvent Free Condition
1,2-Diketones have been reacted in one-pot method with 1,2-diamines at room temperature with ZnO nanoparticles as a catalyst. ZnO nanoparticles as an available and reusable catalyst is used for the synthesis of Quinoxalinein improved yields.
متن کامل